Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoryl transfer enzymes are a broad and diverse class of proteins, including kinases and phosphatases, that catalyze the movement of a phosphate group from a donor molecule to an acceptor (Lassila, J. K., et al., Annu Rev Biochem, 2011). These enzymes play a pivotal role in cellular signaling, metabolism, and energy transfer by acting as molecular switches that regulate protein activity and localization (Westheimer, F. H., Science, 1987). They are formally classified under EC 2.7 and are essential for fundamental biological processes such as glycolysis, DNA replication, and the cell cycle (UniProt, 2024). Dysregulation of these enzymes, particularly protein kinases, is a primary driver of various diseases including cancer, where constitutive activation leads to uncontrolled cell proliferation and survival (Manning, G., et al., Science, 2002). Pharmacological intervention typically involves small-molecule inhibitors that compete with ATP or allosterically modulate the enzyme's conformation to prevent signaling (Zhang, J., et al., Nat Rev Cancer, 2009). Additionally, many antiviral therapies target viral phosphoryl transfer enzymes, such as polymerases, to inhibit genome replication (De Clercq, E., Nat Rev Drug Discov, 2002). However, the high structural conservation of the catalytic domains across this superfamily presents significant challenges for achieving drug selectivity and avoiding off-target toxicities (Knight, Z. A., et al., Nat Rev Cancer, 2005).
Inhibition of phosphate group transfer by competing with the phosphate donor (typically ATP) or the substrate, or through allosteric modulation of the enzyme's catalytic conformation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoryl transfer enzyme.